Gene-editing specialist Seamless Therapeutics has attracted its first major pharma partner, Eli Lilly, with a $1.12 billion alliance that will seek out therapies for hearing loss.
When you buy through our links, Business Insider may earn an affiliate commission. Learn more Wearing white shorts is a gamble for obvious reasons, but will that stop us from wearing them? Certainly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results